Functions of CD40 and its Ligand, gp39 (CD40L)

被引:143
作者
Laman, JD
Claassen, E
Noelle, RJ
机构
[1] DARTMOUTH COLL SCH MED,DEPT MICROBIOL,LEBANON,NH 03756
[2] TNO PREVENT & HLTH,DIV INFECT DIS & IMMUNOL,2301 CE LEIDEN,NETHERLANDS
关键词
CD40; Ligand; gp39; lymphocyte activation; signal transduction; tolerance; cognate T and B cell interaction; antibody; isotype switching; autoimmunity; immunotherapy;
D O I
10.1615/CritRevImmunol.v16.i1.40
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Initially, a role for the interaction between CD40, expressed on B cells, and gp39 (CD40L), expressed on activated T cells, has been defined in humoral immunity. CD40-CD40L interaction is an essential signal for B cell proliferation, expression of activation markers, immunoglobulin production, and isotype switching. CD40-CD40L interaction is also required for formation of B memory cells and germinal centers, and signaling through CD40 prevents apoptosis of germinal center B cells. Defective expression of CD40L in humans leads to an inability to produce isotypes other than IgM (hyper IgM syndrome), and to an absence of germinal centers. More recent evidence indicates an expansion of the role of the CD40-CD40L axis in cellular interactions beyond antibody formation. Induced expression of CD40 on monocytes can lead to CD40L-activated monocyte effector mechanisms. In addition, CD40-CD40L interactions are crucially involved in development of autoimmune disease in a number of animal models. CD40-CD40L interactions also impact on growth regulation of certain carcinomas. Manipulation of CD40L has also been used to develop novel strategies for long-term antigen-specific tolerization of peripheral T cells. Finally, the CD40-CD40L axis is involved in thymic selection. Following is a comprehensive overview of CD40L-CD40 interactions in physiological and pathogenic cellular responses and a discussion of the therapeutic ramifications of these interactions.
引用
收藏
页码:59 / 108
页数:50
相关论文
共 285 条
  • [1] NEUROPEPTIDES ARE POTENT MODULATORS OF HUMAN IN-VITRO IMMUNOGLOBULIN-E SYNTHESIS
    AEBISCHER, I
    STAMPFLI, MR
    ZURCHER, A
    MIESCHER, S
    URWYLER, A
    FREY, B
    LUGER, T
    WHITE, RR
    STADLER, BM
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (08) : 1908 - 1913
  • [2] CD40 EXPRESSION BY HUMAN MONOCYTES - REGULATION BY CYTOKINES AND ACTIVATION OF MONOCYTES BY THE LIGAND FOR CD40
    ALDERSON, MR
    ARMITAGE, RJ
    TOUGH, TW
    STROCKBINE, L
    FANSLOW, WC
    SPRIGGS, MK
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (02) : 669 - 674
  • [3] CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME
    ALLEN, RC
    ARMITAGE, RJ
    CONLEY, ME
    ROSENBLATT, H
    JENKINS, NA
    COPELAND, NG
    BEDELL, MA
    EDELHOFF, S
    DISTECHE, CM
    SIMONEAUX, DK
    FANSLOW, WC
    BELMONT, J
    SPRIGGS, MK
    [J]. SCIENCE, 1993, 259 (5097) : 990 - 993
  • [4] Armitage R J, 1993, Semin Immunol, V5, P401
  • [5] IDENTIFICATION OF A SOURCE OF BIOLOGICALLY-ACTIVE CD40 LIGAND
    ARMITAGE, RJ
    SATO, TA
    MACDUFF, BM
    CLIFFORD, KN
    ALPERT, AR
    SMITH, CA
    FANSLOW, WC
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) : 2071 - 2076
  • [6] ARMITAGE RJ, 1995, J IMMUNOL, V154, P483
  • [7] ARMITAGE RJ, 1993, J IMMUNOL, V150, P3671
  • [8] MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF A MURINE LIGAND FOR CD40
    ARMITAGE, RJ
    FANSLOW, WC
    STROCKBINE, L
    SATO, TA
    CLIFFORD, KN
    MACDUFF, BM
    ANDERSON, DM
    GIMPEL, SD
    DAVISSMITH, T
    MALISZEWSKI, CR
    CLARK, EA
    SMITH, CA
    GRABSTEIN, KH
    COSMAN, D
    SPRIGGS, MK
    [J]. NATURE, 1992, 357 (6373) : 80 - 82
  • [9] CD40 LIGAND IS A T-CELL GROWTH-FACTOR
    ARMITAGE, RJ
    TOUGH, TW
    MACDUFF, BM
    FANSLOW, WC
    SPRIGGS, MK
    RAMSDELL, F
    ALDERSON, MR
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (09) : 2326 - 2331
  • [10] GENERATION OF MEMORY B-CELLS AND PLASMA-CELLS IN-VITRO
    ARPIN, C
    DECHANET, J
    VANKOOTEN, C
    MERVILLE, P
    GROUARD, G
    BRIERE, F
    BANCHEREAU, J
    LIU, YJ
    [J]. SCIENCE, 1995, 268 (5211) : 720 - 722